54 Background -Juvenile idiopathic arthritis (JIA) is one of the most common chronic 55 conditions of childhood. Like many common chronic human illnesses, JIA likely involves 56 complex interactions between genes and the environment, mediated by the epigenome.
Introduction

106
Gene-environment interactions are thought to mediate many complex human traits, 107 including human diseases [1], [2] . It is becoming increasingly clear that the influences of 108 environment (broadly considered) are mediated through epigenetic changes to DNA and Thermo Scientific, Wilmington, DE) and assessed for quality by capillary gel 232 electrophoresis (Agilent 2100 Bioanalyzer; Agilent Technologies, Inc., Palo Alto, CA).
233
Single-end cDNA libraries were prepared for each sample and sequenced using the 
251
Chromatin immunoprecipitation for histone marks H3K4me1 and H3K27ac and 252 sequencing. Neutrophils were isolated as described previously [16] . The ChIP assay 253 was carried out according to the protocol of manufacturer (Cell Signaling Technologies 254 Inc., Danvers, MA, USA). Briefly, adult neutrophils were incubated with newly prepared 255 1% formaldehyde in 10 ml PBS for 10 min at room temperature (RT). Crosslinking was 256 quenched by adding 1× glycine and incubation for 5 min at RT. The crosslinked samples were centrifuged at 800 x g for 5 min. The supernatant was discarded, and the pellet 258 was washed two times with cold PBS followed by resuspension in 10 ml ice-cold Buffer 259 A plus DTT, PMSF and protease inhibitor cocktail. Cells were incubated on ice for 10 260 minutes and centrifuged at 800 x g for 5 min at 4°C to precipitate nuclei pellets, which 261 were then resuspended in 10 ml ice-cold Buffer A plus DTT. The nuclei pellet was edgeR [28] was then applied to discover initial DERs between ADU and HC, the P-value 310 and fold-change (FC) threshold were decided according to volcano plot. (FDR < 0.001 311 for H3K27ac and FDR < 0.05 for H3K4me1 in ADU vs. HC; FC cutoff was set to 2). The
312
DERs exhibited distinct variability between ADU and HC for both H3K27ac and 313 H3K4me1, demonstrating distinct clusters that allowed accurately classification of each 314 sample (Figure 1a ). MACS2 bdgbroadcall [26] was applied to obtain the broad DERs 315 which were used in further analysis from the initial DERs. The lower cutoff of FDR was 316 set to 0.05 for H3K27ac and 0.1 for H3K4me1, the lower cutoff of FC was set to 1.5. The
317
initial DERs between ADU and ADT were obtained using a P value < 0.005 and FC > 2 318 for both H3K27ac and H3K4me1. To call broad DERs, the lower cutoff of P value was 319 set to 0.05 and FC was set to 1.5. The intersection of broad DERs gained or lost in the 320 ADU group in both ADU vs. HC and ADU vs. ADT were considered as regions 321 significantly affected by treatment. To obtain the treatment-unique DERs, we treated 322 ADU and HC together as one group and compared them with ADT. The initial DERs
323
were obtained from edgeR [28] using P value < 0.001 and FC > 2. For broad DER 324 calling, the lower cutoff for P value was 0.05 and 1.5 for FC. The broad DERs obtained 325 by the method were then intersected with the regions considered as similar between 326 ADU and HC (log2FC < 0.1 as peak cutoff and log2FC < 0.2 as linking peaks cutoff in 
338
Whole Genome Sequencing (WGS). We performed WGS on the Illumina X Ten 339 platform on 50 samples from 48 individuals with JIA (duplicates were sequenced to 340 assess quality and fidelity of the sequencing data). Of these, 37 subjects were girls and 341 11 were boys. All patients were of European descent (n=33) or mixed European-
342
American Indian descent (n=5). We have recently published a preliminary analysis of 343 these data [30] .
344
We used BWA [25] to map sequencing reads of each sample with respect to the human 345 reference genome hg19. Potential artifacts caused by PCR duplicated reads were 346 removed using Picard tools (http://picard.sourceforge.net.). Genome Analysis Toolkit 347 (GATK version 3.2-2-gec30cee) 36 was used to refine reads around small insertions or 348 deletions (indels) and recalibrate base quality scores. We adopted the GATK best 349 practices in calling SNPs, small insertion or deletion (indels) between 1 and 50 bp in 
380
Fisher exact test's p-value was computed to gauge the significance of the observed 381 differences. The odds ratio of the Fisher exact test was used as enrichment fold. Using 382 this approach, we tested whether there were more genetic variants derived from JIA 
388
We have made the data available to the scientific community. WGS bam files have 389 been uploaded to NCBI bioproject: 390 https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA343545 .
391
WGS snps/indels were uploaded to dbsnp149: handle id: JJLAB. WGS structural 392 variatiants were submitted to DGVa id: estd231 393 https://www.ncbi.nlm.nih.gov/dbvar/studies/estd231/ .
394
Other data were uploaded to the Gene Expression Omnibus (GEO). The GEO 395 accession number for the RNA-Seq in neutrophils is GSE92293, for ChIP-Seq of 396 H3K27ac and H3K4me1 in neutrophils is GSE92393, and for DNA methylation in 397 neutrophils is GSE92749.
399
Results
400
As noted in our Introduction, our goal in this study was to test the feasibility of generating 
442
In addition to corroborating our previous findings, the RNA-Seq studies show 443 that reference "maps" of disease-specific epigenomes will need to be generated for 444 specific disease states (e.g., untreated disease, disease that is active, disease that is in 445 remission, etc). These studies further highlight the desirability of creating these maps 
454
We studied neutrophils collected from children with active, untreated JIA (ADU: 2 455 individuals) and healthy controls (HC: 3 individuals). We first used ChIP-Seq to study 456 two histone marks, H3K27ac and H3K4me1, typically associated with enhancer activity.
457
We binned the human genome, then used edgeR [28] to call H3K4me1 and H3K27ac
458
DERs with significant and robust alterations in ChIP-Seq signals (See Methods for 459 detail). The definition and analysis of DERs between ADU and HC are shown in Figure   460 1a, 1b. We identified 3,610 (average length: 3610 bps) H3K27ac and 5,098 (average 461 length: 781 bps) H3K4me1 DERs gained in the ADU group (i.e., regions that were more 462 enriched with histone modifications in the ADU than in the HC group). We also identified 463 H3K4me1 or H3K27ac in the HC group than in the ADU group). We note that ADU 
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In contrast, the DMRs identified between ADU and HC were not significantly 514 associated with differential gene expression when considering hyper-and hypo-515 methylated regions separately. We designated the genes that were (-5Kbs, 5Kbs) of 516 TSS or whose gene bodies intersected with DMRs as DMR-associated genes. We 517 identified 160 expressed genes associated with hypermethylated DMRs and 100 518 expressed genes associated with hypomethylated DMRs in the ADU group (S.Table6).
519
However, GO analyses did not reveal any significantly enriched terms in biological 520 processes. Only three ADU hypermethylated DMR-associated genes (ADARB2,
521
CNTNAP3B, and MYOM2) showed significant differential expression in the ADU vs. HC 
536
(compared to HC) showed decreased H3K27ac or H3K4me1 marks after treatment 537 (Figure S3a,3b) . We identified 470 (average length: 705 bps) DERs gained H3K27ac in 538 ADU compared with HC but then lost H3K27ac in ADT, and 818 (average length: 460 539 bps) gained H3K4me1 in ADU then lost in ADT (Figure 3a) . In other words, after 540 treatment, these regions gaining the histone marks in the active disease state changed 541 significantly toward levels identified in HC (Figure 3c, 3d) ; we designate these as "gain-then-loss" DERs. On the other hand, a smaller number of DERs (33 for H3K27ac and 543 13 for H3K4me1) gained H3K27ac or H3K4me1 in the ADU compared with HC and 544 showed a further, significant H3K27ac or H3K4me1 gain in ADT vs ADU. We also 545 detected the "loss-then-regain" DERs, that is, 55 (average length: 494 bps) H3K27ac
546
DERs lost in ADU but then regain the mark in ADT and 140 (average length: 322 bps)
547
DERs lost H3K4me1 in ADU then regain it in ADT (Figure 3b) . These regions also 548 demonstrated histone marks that were more similar, compared with the gain-then-loss 549 DERs, to HC after the initiation of treatment (Figure 3c, 3d) . Only a minority (4 for show similar expression levels in ADU, HC and ADT groups (Figure S3c,3d) . with the non-ADT groups (Figure 3f) . This finding indicates that, after treatment, the 572 histone marks of these regions changed to a unique state other than ADU and HC 573 (Figure 3g, 3h) . The expressed genes associated with those ADT unique DERs are 574 displayed in S. Table 9 .
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Taken together, these findings demonstrate that, even for functional signatures such 
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We identified 1,072 differentially methylated regions (DMRs), of 500bps each, when 592 comparing ADU with HC subjects. Of these, 705 were hyper-methylated and 367 were 593 hypo-methylated in the ADU group (Figure S2a) . These DMRs were enriched in distal methylated regions (DMRs) identified in JIA neutrophils were located within the 26 LD 621 blocks harboring JIA-associated SNPs, but found none.
622
These findings point to the utility of this approach. The regions where known genetic 623 risk for JIA is associated with alterations in the functional epigenome will be of special 624 interest to investigators interested in the mechanisms through which genetic variance 625 alters non-coding genome function. Furthermore, these data provide a map that will 626 sharply reduce the proportion of the involved haplotypes that need to be investigated 627 (and therefore the number of SNPs that need to be tested) in functional assays. They 628 also suggest that, at least in neutrophils, DNA methylation may not be an informative 
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Taken together, these small, independently-acquired data sets do not indicate a strong 690 association between genetic variation (as identified by the WGS data) and epigenetic 691 alterations in JIA neutrophils. It seems likely that specific, directed experiments will be 692 required to identify allelic effects on epigenetic signals at specific genomic locations [38] .
Discussion
695
In the current work, we demonstrate the feasibility of developing informative, multi-696 dimensional genomic maps of JIA to study the interplay between genetics and 697 epigenetics in this common childhood disease. We took the same approach used by the 698 NIH ENCODE and Roadmap Epigenomics projects, seeking to gather the largest 699 amount of information from the smallest number of samples as possible. We started by 700 assuring ourselves that this parsimonious approach could recapitulate findings we have 718 that we can corroborate findings from studies that were generated using larger numbers 719 of samples supports the utility of generating such maps using small sample numbers.
720
The presence of novel epigenetic marks in JIA neutrophils did not broadly reflect 721 underlying genetic variation as determined from either whole genome sequencing or 722 reference to previously identified JIA-associated SNPs/haplotypes. We could account 723 for no more than 26% of the epigenetic variation, as reflected in histone marks, in JIA 
741
Our study pinpoints one environmental factor that is impacts neutrophil epigenomes:
742 the initiation of effective therapy. This study is the first, to our knowledge, to demonstrate 743 that effective therapy for a chronic human disease alters the epigenome. Furthermore,
744
alterations in the epigenome associated with therapy tended to "correct" the neutrophil 745 epigenome closer to patterns found in the cells of healthy children, as shown in Figure  S3 . Alterations in enhancer location included both poised (H3K4me1 marks) and active 747 (H327ac marks) enhancers. Furthermore, even with this small number of samples, we 748 were able to associate alterations in enhancer locations with alterations in gene 749 expression. These findings support the idea that building genomic maps for each stage 750 of therapy, from active disease through remission, as defined by the Wallace criteria [43] 751 may be a useful approach to understanding the underlying biology of therapeutic 752 response.
753
It was interesting to note that we did not see a strong correlation between changes in 
